Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wang, Zhongqiu ^a,b   Sturgis, Erich M ^a   Guo, Wei ^a,c   Song, Xicheng ^a,d   Zhang, Fenghua ^a,e   Xu, Li ^a   Wei, Qingyi ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d YANTAI YUHUANGDING HOSPITAL   (China)

^e HEBEI GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENOMIC DNA; PROLINE; PROTEIN P53; PROTEIN P73; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TP53 PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE P53; ONCOGENE P73; OROPHARYNX CANCER; PATHOGENESIS; SMOKING; AGED; GENETICS; MIDDLE AGED; OROPHARYNX TUMOR; STATISTICAL MODEL; TUMOR SUPPRESSOR GENE; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; GENES, P53; HUMAN PAPILLOMAVIRUS 16; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OROPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84859853653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035522     Document Type: Article

References (47)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK, (1933) Head and neck cancer. N Engl J Med 328: 184-194.
2. Dobrossy L, (2005) Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24: 9-17.
3. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720.
4. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D, (1999) Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 109: 1544-1551.
5. Haughey BH, Hinni ML, Salassa JR, Hayden RE, Grant DG, et al. (2011) Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 33: 1683-1694.
6. Rich JT, Liu J, Haughey BH, (2011) Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 121: 2381-2390.
7. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, et al. (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100: 407-420.
8. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, et al. (2003) Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104: 336-344.
9. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E, (2002) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304.
10. Li W, Thompson CH, O'Brien CJ, McNeil EB, Scolyer RA, et al. (2003) Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106: 553-558.
11. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM, (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92: 805-813.
12. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, et al. (2004) Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108: 766-772.
13. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
14. Helton ES, Chen X, (2000) p53 modulation of the DNA damage response. J Cell Biochem 100: 883-896.
15. Jost CA, Marin MC, Kaelin WG, (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389: 191-194.
16. Melino G, De Laurenzi V, Vousden KH, (2002) p73: friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615.
17. Fakhry C, Gillison ML, (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24: 2606-2611.
18. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, et al. (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772-1783.
19. Munger K, Howley PM, (2002) Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228.
20. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM, (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
21. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM, (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
22. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, et al. (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100.
23. Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M, (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365.
24. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, et al. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234.
25. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819.
26. Haber DA, Fearon ER, (1998) The promise of cancer genetics. Lancet 351 (Suppl 2): SII1-8.
27. Guan X, Sturgis EM, Lei D, Liu Z, Dahlstrom KR, et al. (2010) Association of TGF-β1 Genetic Variants with HPV16-positive Oropharyngeal Cancer. Clin Cancer Res 16: 1416-1422.
28. Park JS, Kim EJ, Lee JY, Sin HS, Namkoong SE, et al. (2001) Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer 91: 822-827.
29. Li G, Sturgis EM, Wang LE, Chamberlain RM, Amos CI, et al. (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 25: 1911-1916.
30. Li F, Sturgis EM, Zafereo M, Wei Q, Li G, (2010) Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer 116: 2350-2359.
31. Ji X, Neumann AS, Sturgis EM, Wei Q, Li G, (2008) p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers. Carcinogenesis 29: 875-879.
32. Chen X, Sturgis EM, Etzel CJ, Wei Q, Li G, (2008) p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer 113: 307-314.
33. Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, et al. (2007) p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer 109: 2461-2465.
34. Chen X, Sturgis EM, El-Naggar AK, Wei Q, Li G, (2008) Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 29: 2120-2125.
35. Ji X, Sturgis EM, Zhao C, Wei Q, Li G, (2009) Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic Whites. Cancer 115: 1660-1668.
36. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M, (1999) Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 85: 1903-1909.
37. Báez A, Almodóvar JI, Cantor A, Celestin F, Cruz-Cruz L, et al. (2004) High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 26: 778-784.
38. Koskinen WJ, Chen RW, Leivo I, Mäkitie A, Bäck L, et al. (2003) Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107: 401-406.
39. Melino G, Lu X, Gasco M, Crook T, Knight RA, (2003) Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28: 663-670.
40. Werness BA, Levine AJ, Howley PM, (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
41. Phillips AC, Vousden KH, (2001) E2F-1 induced apoptosis. Apoptosis 6: 173-182.
42. Das S, Somasundaram K, (2006) Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papillomavirus positive cervical cancer in vitro and in vivo. Cancer Biol Ther 5: 210-217.
43. Dahlstrom KR, Adler-Storthz K, Etzel CJ, Wei Q, Strugis EM, (2003) Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 9: 2620-2626.
44. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, et al. (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623.
45. Favre A, Paoli D, Poletti M, Marzoli A, Giampalmo A, et al. (1986) The human palatine tonsil studied from surgical specimens at all ages and in various pathological conditions. 1. Morphological and structural analyses. Z Mikrosk Anat Forsch 100: 7-33.
46. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL, (1997) Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 123: 513-516.
47. Huang CC, Qiu JT, Kashima ML, Karman RJ, Wu TC, (1998) Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 11: 971-977.